Tempus AI Total Liabilities 2023-2025 | TEM
Tempus AI total liabilities from 2023 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
- Tempus AI total liabilities for the quarter ending March 31, 2025 were $1.217B, a 37.39% decline year-over-year.
- Tempus AI total liabilities for 2024 were $0.87B, a 55.31% decline from 2023.
- Tempus AI total liabilities for 2023 were $1.946B, a 10.56% increase from 2022.
- Tempus AI total liabilities for 2022 were $1.76B, a 0% decline from .
| Tempus AI Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $870 |
| 2023 | $1,946 |
| 2022 | $1,760 |
| Tempus AI Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2025-03-31 | $1,217 |
| 2024-12-31 | $870 |
| 2024-09-30 | $918 |
| 2024-06-30 | $766 |
| 2024-03-31 | $1,944 |
| 2023-12-31 | $1,946 |
| 2023-09-30 | $0 |
| 2023-06-30 | $0 |
| 2023-03-31 | $0 |
| 2022-12-31 | $1,760 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $12.393B | $0.693B |
| Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $44.935B | 57.17 |
| Doximity (DOCS) | United States | $11.901B | 52.95 |
| Hims & Hers Health (HIMS) | United States | $10.549B | 87.28 |
| IRhythm Technologies (IRTC) | United States | $5.208B | 0.00 |
| Hinge Health (HNGE) | United States | $4.462B | 0.00 |
| Privia Health (PRVA) | United States | $2.542B | 188.27 |
| Inspire Medical Systems (INSP) | United States | $2.501B | 36.77 |
| Phreesia (PHR) | United States | $1.667B | 0.00 |
| Enovis (ENOV) | United States | $1.647B | 8.71 |
| 10x Genomics (TXG) | United States | $1.630B | 0.00 |
| Omnicell (OMCL) | United States | $1.446B | 27.85 |
| Schrodinger (SDGR) | United States | $1.427B | 0.00 |
| Azenta (AZTA) | United States | $1.402B | 61.18 |
| Clover Health Investments (CLOV) | United States | $1.317B | 0.00 |
| Claritev (CTEV) | United States | $1.117B | 0.00 |
| Evolent Health (EVH) | United States | $1.035B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.665B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.509B | 0.00 |
| Veradigm (MDRX) | United States | $0.498B | 0.00 |
| Standard BioTools (LAB) | United States | $0.463B | 0.00 |
| Talkspace (TALK) | United States | $0.424B | 126.50 |
| Carlsmed (CARL) | $0.370B | 0.00 | |
| Butterfly Network (BFLY) | United States | $0.355B | 0.00 |
| TruBridge (TBRG) | United States | $0.287B | 50.40 |
| Nyxoah SA (NYXH) | Belgium | $0.232B | 0.00 |
| Outset Medical (OM) | United States | $0.229B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.222B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.206B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.190B | 0.00 |
| CapsoVision (CV) | United States | $0.186B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.134B | 0.00 |
| American Well (AMWL) | United States | $0.117B | 0.00 |
| CareCloud (CCLD) | United States | $0.108B | 4.92 |
| EUDA Health Holdings (EUDA) | Singapore | $0.097B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.093B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.069B | 0.00 |
| Pulmonx (LUNG) | United States | $0.062B | 0.00 |
| 111 (YI) | China | $0.057B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.050B | 0.00 |
| HeartBeam (BEAT) | United States | $0.038B | 0.00 |
| Zhongchao (ZCMD) | China | $0.024B | 0.00 |
| Precipio (PRPO) | United States | $0.024B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.019B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.005B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| PROFUSA (PFSA) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |